Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Neuropharmacology. 2008 Sep 25;56(2):368–378. doi: 10.1016/j.neuropharm.2008.09.007

Fig. 8.

Fig. 8

The effects of β-NAD (A, B), adenosine (ADO, C, D) and ATP (E, F) in the absence (closed squares) and presence of the P1 receptor antagonist 8-p-sulfophenyltheophylline (8-SPT, 100 μM) in the canine mesenteric artery (left column) and vein (right column). Data represent mean±SEM from 2–6 experiments. The asterisks denote significant difference from controls in the absence of 8-SPT, P<0.05.